Lipids Perspective

• New Revascularization Guidelines: Key Points and Controversies   Bob Harrington interviews fellow cardiologist Jacqueline Tamis-Holland, vice chair of the recent ACC/AHA revascularization guidelines. She lets us inside the process and responds to the controversy.
  theheart.org on Medscape, April 25, 2022
• Top Abstracts in Atherosclerosis and Lipid Management From ACC 2022   Key data on atherosclerosis and lipids from ACC 2022 include PACMAN-AMI results with alirocumab, a new look at waist circumference in REDUCE-IT, and a subgroup analysis of SCORED with sotagliflozin.
  Medscape, April 25, 2022
• ESCPrev 2022 Read clinically focused news coverage of key developments from ESCPrev 2022
  theheart.org on Medscape, April 19, 2022
• Type 2 Diabetes With ASCVD   Experts in endocrinology and cardiology evaluate a patient with troubling risk factors for cardiovascular disease and discuss the potential benefits of new therapies and lifestyle modifications.
  Medscape, April 19, 2022
• Episode 3: How to Reduce Renal Risk in Type 2 Diabetes   Want to prevent kidney disease progression in patients with type 2 diabetes? Join host Dr Silvio Inzucchi and nephrologist Dr David Cherney as they unpack the how and why behind current recommendations.
  Medscape, April 13, 2022
• Contrast-Associated Acute Kidney Injury Is a Meaningless Endpoint A change in lingo and a new risk score don't diminish this nephrologist's skepticism about the clinical significance of contrast-associated nephropathy.
  theheart.org on Medscape, April 12, 2022
• American College of Cardiology 2022: Four Trials Concerning Lipid Management   Erin D. Michos, MD, addresses the results of four key trials presented at ACC 2022: APOLLO, PACMAN-AMI, SuperWIN, and TRANSLATE-TIMI 70.
  Medscape, April 08, 2022
• ACC 2022: A Step Towards Prime Time for a Breakthrough in Lipid Management   Anum Saeed, MD, reports on the encouraging results of the APOLLO trial presented at ACC 2022.
  Medscape, April 07, 2022
• Is Saturated Fat or Carbohydrates Worse for the Liver? Dr. Caroline Apovian discusses whether fat or carbohydrate overfeeding is more likely to lead to the development of nonalcoholic fatty liver disease.
  Medscape Diabetes & Endocrinology, April 07, 2022
• ACC 2022 SuperWIN: Supermarket Partnership Improves DASH Diet Score   In a novel trial, DASH diet scores improved after participants were taught how to shop for healthier food, whether online or instore. Investigator Dylan Steen shares the details.
  theheart.org on Medscape, April 06, 2022
• American College of Cardiology 2022: New Data on Lipids From the APOLLO Study   Anum Saeed, MD, speculates on forthcoming data from current studies that will be presented at ACC 2022.
  Medscape, April 06, 2022
• ACC 2022 Percutaneous Left Atrial Appendage Occlusion: Promise vs Reality The selling point of percutaneous left atrial appendage occlusion is to prevent stroke while avoiding the bleeding risk of antithrombotics. The data paint a different picture, writes John Mandrola, MD.
  theheart.org on Medscape, April 04, 2022
• A Look Ahead to ACC 2022: Late-Breaking Clinical Trials in Lipid Management   Erin D. Michos, MD, MHS, looks forward to the results of late-breaking clinical trials in the field of lipid management and the prevention of cardiovascular events at ACC 2022.
  Medscape, April 04, 2022
• Mar 25 2022 This Week in Cardiology   AF ablation vs rate control in HF, TAVI vs SAVR, atherosclerosis, and surrogate endpoints in observational studies are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, March 25, 2022
• ACC 2022 Read clinically focused news coverage of key developments from ACC 2022
  theheart.org on Medscape, March 25, 2022
• Episode 2: A Brave New World in Type 2 Diabetes Treatment and Beyond   Where are the biggest cardiovascular benefits for your patients with type 2 diabetes? Host Silvio Inzucchi and cardiologist Mikhail Kosiborod reveal winning strategies -- for managing much more than just type 2 diabetes.
  Medscape, March 22, 2022
• Episode 1: High-Impact Type 2 Diabetes Treatment Guidelines   Huge improvements in treatments for type 2 diabetes are outlined in recent diabetes guidelines. Get the upshot on best evidence from leading experts Drs Silvio Inzucchi and Rita Kalyani.
  Medscape, March 22, 2022
• Is Diabetes a Cardiovascular Risk Equivalent?   Drs Jay Shubrook and Mark Villalon discuss cardiovascular risk stratification and management in patients with diabetes.
  American College of Cardiology & Medscape , March 15, 2022
• COVID-19 and the Heart: Is Cardiology Ready?   Robert Harrington, MD, interviews Ziyad Al-Aly, MD, about his recent paper in Nature Medicine focused on the long-term cardiovascular effects of COVID-19.
  theheart.org on Medscape, March 14, 2022
• EPI 2022 Read clinically focused news coverage of key developments from EPI 2022
  theheart.org on Medscape, March 03, 2022